This protocol applies to patients with sarcoidosis who have posterior uveitis or panuveitis — presentations in which the posterior segment of the eye is involved and systemic treatment is typically required.
When sarcoidosis involves posterior uveitis or panuveitis, systemic therapy is usually indicated rather than local measures alone. The extent and location of ocular inflammation in these presentations guide the treatment decision.
The protocol incorporates systemic corticosteroid therapy, which is generally effective in controlling inflammation in this setting. Local corticosteroid delivery to the eye may also form part of the approach — the complete regimen, full sequencing, and all options are detailed in the structured protocol below.
For posterior uveitis or panuveitis, systemic therapy is usually used.
Systemic corticosteroids are usually effective in controlling inflammation in both the short and long term.
View source ↗